Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists
A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding modes of A2AAR antagonists and agonists were compared by...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2003-11, Vol.46 (23), p.4847-4859 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4859 |
---|---|
container_issue | 23 |
container_start_page | 4847 |
container_title | Journal of medicinal chemistry |
container_volume | 46 |
creator | Kim, Soo-Kyung Gao, Zhan-Guo Van Rompaey, Philippe Gross, Ariel S Chen, Aishe Van Calenbergh, Serge Jacobson, Kenneth A |
description | A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding modes of A2AAR antagonists and agonists were compared by using the FlexiDock automated docking procedure, with manual adjustment. Putative binding regions for the 9H-purine ring in agonist NECA 3 and the 1H-[1,2,4]triazolo[1,5-c]quinazoline ring in antagonist CGS15943 1 overlapped, and the exocyclic amino groups of each were H-bonded to the side chain of N6.55. For bound agonist, H-bonds formed between the ribose 3‘- and 5‘-substituents and the hydrophilic amino acids T3.36, S7.42, and H7.43, and the terminal methyl group of the 5‘-uronamide interacted with the hydrophobic side chain of F6.44. Formation of the agonist complex destabilized the ground-state structure of the A2AAR, which was stabilized through a network of H-bonding and hydrophobic interactions in the transmembrane helical domain (TM) regions, facilitating a conformational change upon activation. Both flexibility of the ribose moiety, required for the movement of TM6, and its H-bonding to the receptor were important for agonism. Two sets of interhelical H-bonds involved residues conserved among ARs but not in rhodopsin: (1) E131.39 and H2787.43 and (2) D522.50, with the highly conserved amino acids N2807.45 and S2817.46, and N2847.49 with S913.39. Most of the amino acid residues lining the putative binding site(s) were conserved among the four AR subtypes. The A2AAR/3 complex showed a preference for an intermediate conformation about the glycosidic bond, unlike in the A3AR/3 complex, which featured an anti-conformation. Hydrophilic amino acids of TMs 3 and 7 (ribose-binding region) were replaced with anionic residues for enhanced binding to amine-derivatized agonists. We identified new neoceptor (T88D)-neoligand pairs that were consistent with the model. |
doi_str_mv | 10.1021/jm0300431 |
format | Article |
fullrecord | <record><control><sourceid>istex_pubme</sourceid><recordid>TN_cdi_pubmed_primary_14584936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_XBMKS082_0</sourcerecordid><originalsourceid>FETCH-LOGICAL-a220t-c6e2102afd5de534b504708d20462390cea4a6e3ff307645cfd62c843a4c044a3</originalsourceid><addsrcrecordid>eNpFkU1PwkAQhjdGI4ge_AOmF4_V6e62FG8FPyNEI5h42wz7gUW623RLojev_k1_iUVQTpOZeebNvHkJOY7gLAIanc8LYACcRTukHcUUQp4C3yVtAEpDmlDWIgfezwGARZTtk1bE45T3WNImZuSUXuR2FtSvOsiUts7nVgdPWuqydpW_-P78CgauKLHKvbOBM79kP7dqdXXpCsytX40zmgXZzNnc1z5Aq4LM1rjpD8mewYXXR5vaIc_XV5PBbTh8uLkbZMMQKYU6lImmjSM0KlY6ZnwaA-9CqijwxkUPpEaOiWbGMOgmPJZGJVSmnCGXwDmyDjlZ65bLaaGVKKu8wOpD_BlugNMNgF7iwlRoZe63XEwbDHoNF6655nv9_r_H6k0kXdaNxeRxLF76o_sxpFTAVhelF3O3rGxjU0QgVgGJ_4DYD3nMfmQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Kim, Soo-Kyung ; Gao, Zhan-Guo ; Van Rompaey, Philippe ; Gross, Ariel S ; Chen, Aishe ; Van Calenbergh, Serge ; Jacobson, Kenneth A</creator><creatorcontrib>Kim, Soo-Kyung ; Gao, Zhan-Guo ; Van Rompaey, Philippe ; Gross, Ariel S ; Chen, Aishe ; Van Calenbergh, Serge ; Jacobson, Kenneth A</creatorcontrib><description>A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding modes of A2AAR antagonists and agonists were compared by using the FlexiDock automated docking procedure, with manual adjustment. Putative binding regions for the 9H-purine ring in agonist NECA 3 and the 1H-[1,2,4]triazolo[1,5-c]quinazoline ring in antagonist CGS15943 1 overlapped, and the exocyclic amino groups of each were H-bonded to the side chain of N6.55. For bound agonist, H-bonds formed between the ribose 3‘- and 5‘-substituents and the hydrophilic amino acids T3.36, S7.42, and H7.43, and the terminal methyl group of the 5‘-uronamide interacted with the hydrophobic side chain of F6.44. Formation of the agonist complex destabilized the ground-state structure of the A2AAR, which was stabilized through a network of H-bonding and hydrophobic interactions in the transmembrane helical domain (TM) regions, facilitating a conformational change upon activation. Both flexibility of the ribose moiety, required for the movement of TM6, and its H-bonding to the receptor were important for agonism. Two sets of interhelical H-bonds involved residues conserved among ARs but not in rhodopsin: (1) E131.39 and H2787.43 and (2) D522.50, with the highly conserved amino acids N2807.45 and S2817.46, and N2847.49 with S913.39. Most of the amino acid residues lining the putative binding site(s) were conserved among the four AR subtypes. The A2AAR/3 complex showed a preference for an intermediate conformation about the glycosidic bond, unlike in the A3AR/3 complex, which featured an anti-conformation. Hydrophilic amino acids of TMs 3 and 7 (ribose-binding region) were replaced with anionic residues for enhanced binding to amine-derivatized agonists. We identified new neoceptor (T88D)-neoligand pairs that were consistent with the model.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm0300431</identifier><identifier>PMID: 14584936</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenosine A2 Receptor Agonists ; Adenosine A2 Receptor Antagonists ; Adenosine-5'-(N-ethylcarboxamide) - chemistry ; Adenosine-5'-(N-ethylcarboxamide) - pharmacology ; Animals ; Binding Sites ; Biological and medical sciences ; COS Cells ; Humans ; Hydrogen Bonding ; Hydrophobic and Hydrophilic Interactions ; Ligands ; Medical sciences ; Models, Molecular ; Mutagenesis, Site-Directed ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Protein Conformation ; Quinazolines - chemistry ; Quinazolines - pharmacology ; Radioligand Assay ; Receptors, Adenosine A2 - genetics ; Triazoles - chemistry ; Triazoles - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2003-11, Vol.46 (23), p.4847-4859</ispartof><rights>Copyright © 2003 American Chemical Society</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm0300431$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm0300431$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15249309$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14584936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Soo-Kyung</creatorcontrib><creatorcontrib>Gao, Zhan-Guo</creatorcontrib><creatorcontrib>Van Rompaey, Philippe</creatorcontrib><creatorcontrib>Gross, Ariel S</creatorcontrib><creatorcontrib>Chen, Aishe</creatorcontrib><creatorcontrib>Van Calenbergh, Serge</creatorcontrib><creatorcontrib>Jacobson, Kenneth A</creatorcontrib><title>Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding modes of A2AAR antagonists and agonists were compared by using the FlexiDock automated docking procedure, with manual adjustment. Putative binding regions for the 9H-purine ring in agonist NECA 3 and the 1H-[1,2,4]triazolo[1,5-c]quinazoline ring in antagonist CGS15943 1 overlapped, and the exocyclic amino groups of each were H-bonded to the side chain of N6.55. For bound agonist, H-bonds formed between the ribose 3‘- and 5‘-substituents and the hydrophilic amino acids T3.36, S7.42, and H7.43, and the terminal methyl group of the 5‘-uronamide interacted with the hydrophobic side chain of F6.44. Formation of the agonist complex destabilized the ground-state structure of the A2AAR, which was stabilized through a network of H-bonding and hydrophobic interactions in the transmembrane helical domain (TM) regions, facilitating a conformational change upon activation. Both flexibility of the ribose moiety, required for the movement of TM6, and its H-bonding to the receptor were important for agonism. Two sets of interhelical H-bonds involved residues conserved among ARs but not in rhodopsin: (1) E131.39 and H2787.43 and (2) D522.50, with the highly conserved amino acids N2807.45 and S2817.46, and N2847.49 with S913.39. Most of the amino acid residues lining the putative binding site(s) were conserved among the four AR subtypes. The A2AAR/3 complex showed a preference for an intermediate conformation about the glycosidic bond, unlike in the A3AR/3 complex, which featured an anti-conformation. Hydrophilic amino acids of TMs 3 and 7 (ribose-binding region) were replaced with anionic residues for enhanced binding to amine-derivatized agonists. We identified new neoceptor (T88D)-neoligand pairs that were consistent with the model.</description><subject>Adenosine A2 Receptor Agonists</subject><subject>Adenosine A2 Receptor Antagonists</subject><subject>Adenosine-5'-(N-ethylcarboxamide) - chemistry</subject><subject>Adenosine-5'-(N-ethylcarboxamide) - pharmacology</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>COS Cells</subject><subject>Humans</subject><subject>Hydrogen Bonding</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Mutagenesis, Site-Directed</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Conformation</subject><subject>Quinazolines - chemistry</subject><subject>Quinazolines - pharmacology</subject><subject>Radioligand Assay</subject><subject>Receptors, Adenosine A2 - genetics</subject><subject>Triazoles - chemistry</subject><subject>Triazoles - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1PwkAQhjdGI4ge_AOmF4_V6e62FG8FPyNEI5h42wz7gUW623RLojev_k1_iUVQTpOZeebNvHkJOY7gLAIanc8LYACcRTukHcUUQp4C3yVtAEpDmlDWIgfezwGARZTtk1bE45T3WNImZuSUXuR2FtSvOsiUts7nVgdPWuqydpW_-P78CgauKLHKvbOBM79kP7dqdXXpCsytX40zmgXZzNnc1z5Aq4LM1rjpD8mewYXXR5vaIc_XV5PBbTh8uLkbZMMQKYU6lImmjSM0KlY6ZnwaA-9CqijwxkUPpEaOiWbGMOgmPJZGJVSmnCGXwDmyDjlZ65bLaaGVKKu8wOpD_BlugNMNgF7iwlRoZe63XEwbDHoNF6655nv9_r_H6k0kXdaNxeRxLF76o_sxpFTAVhelF3O3rGxjU0QgVgGJ_4DYD3nMfmQ</recordid><startdate>20031106</startdate><enddate>20031106</enddate><creator>Kim, Soo-Kyung</creator><creator>Gao, Zhan-Guo</creator><creator>Van Rompaey, Philippe</creator><creator>Gross, Ariel S</creator><creator>Chen, Aishe</creator><creator>Van Calenbergh, Serge</creator><creator>Jacobson, Kenneth A</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20031106</creationdate><title>Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists</title><author>Kim, Soo-Kyung ; Gao, Zhan-Guo ; Van Rompaey, Philippe ; Gross, Ariel S ; Chen, Aishe ; Van Calenbergh, Serge ; Jacobson, Kenneth A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a220t-c6e2102afd5de534b504708d20462390cea4a6e3ff307645cfd62c843a4c044a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adenosine A2 Receptor Agonists</topic><topic>Adenosine A2 Receptor Antagonists</topic><topic>Adenosine-5'-(N-ethylcarboxamide) - chemistry</topic><topic>Adenosine-5'-(N-ethylcarboxamide) - pharmacology</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>COS Cells</topic><topic>Humans</topic><topic>Hydrogen Bonding</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Mutagenesis, Site-Directed</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Conformation</topic><topic>Quinazolines - chemistry</topic><topic>Quinazolines - pharmacology</topic><topic>Radioligand Assay</topic><topic>Receptors, Adenosine A2 - genetics</topic><topic>Triazoles - chemistry</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Soo-Kyung</creatorcontrib><creatorcontrib>Gao, Zhan-Guo</creatorcontrib><creatorcontrib>Van Rompaey, Philippe</creatorcontrib><creatorcontrib>Gross, Ariel S</creatorcontrib><creatorcontrib>Chen, Aishe</creatorcontrib><creatorcontrib>Van Calenbergh, Serge</creatorcontrib><creatorcontrib>Jacobson, Kenneth A</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Soo-Kyung</au><au>Gao, Zhan-Guo</au><au>Van Rompaey, Philippe</au><au>Gross, Ariel S</au><au>Chen, Aishe</au><au>Van Calenbergh, Serge</au><au>Jacobson, Kenneth A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2003-11-06</date><risdate>2003</risdate><volume>46</volume><issue>23</issue><spage>4847</spage><epage>4859</epage><pages>4847-4859</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding modes of A2AAR antagonists and agonists were compared by using the FlexiDock automated docking procedure, with manual adjustment. Putative binding regions for the 9H-purine ring in agonist NECA 3 and the 1H-[1,2,4]triazolo[1,5-c]quinazoline ring in antagonist CGS15943 1 overlapped, and the exocyclic amino groups of each were H-bonded to the side chain of N6.55. For bound agonist, H-bonds formed between the ribose 3‘- and 5‘-substituents and the hydrophilic amino acids T3.36, S7.42, and H7.43, and the terminal methyl group of the 5‘-uronamide interacted with the hydrophobic side chain of F6.44. Formation of the agonist complex destabilized the ground-state structure of the A2AAR, which was stabilized through a network of H-bonding and hydrophobic interactions in the transmembrane helical domain (TM) regions, facilitating a conformational change upon activation. Both flexibility of the ribose moiety, required for the movement of TM6, and its H-bonding to the receptor were important for agonism. Two sets of interhelical H-bonds involved residues conserved among ARs but not in rhodopsin: (1) E131.39 and H2787.43 and (2) D522.50, with the highly conserved amino acids N2807.45 and S2817.46, and N2847.49 with S913.39. Most of the amino acid residues lining the putative binding site(s) were conserved among the four AR subtypes. The A2AAR/3 complex showed a preference for an intermediate conformation about the glycosidic bond, unlike in the A3AR/3 complex, which featured an anti-conformation. Hydrophilic amino acids of TMs 3 and 7 (ribose-binding region) were replaced with anionic residues for enhanced binding to amine-derivatized agonists. We identified new neoceptor (T88D)-neoligand pairs that were consistent with the model.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>14584936</pmid><doi>10.1021/jm0300431</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2003-11, Vol.46 (23), p.4847-4859 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pubmed_primary_14584936 |
source | MEDLINE; American Chemical Society Journals |
subjects | Adenosine A2 Receptor Agonists Adenosine A2 Receptor Antagonists Adenosine-5'-(N-ethylcarboxamide) - chemistry Adenosine-5'-(N-ethylcarboxamide) - pharmacology Animals Binding Sites Biological and medical sciences COS Cells Humans Hydrogen Bonding Hydrophobic and Hydrophilic Interactions Ligands Medical sciences Models, Molecular Mutagenesis, Site-Directed Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Pharmacology. Drug treatments Protein Conformation Quinazolines - chemistry Quinazolines - pharmacology Radioligand Assay Receptors, Adenosine A2 - genetics Triazoles - chemistry Triazoles - pharmacology |
title | Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A58%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modeling%20the%20Adenosine%20Receptors:%E2%80%89%20Comparison%20of%20the%20Binding%20Domains%20of%20A2A%20Agonists%20and%20Antagonists&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Kim,%20Soo-Kyung&rft.date=2003-11-06&rft.volume=46&rft.issue=23&rft.spage=4847&rft.epage=4859&rft.pages=4847-4859&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm0300431&rft_dat=%3Cistex_pubme%3Eark_67375_TPS_XBMKS082_0%3C/istex_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14584936&rfr_iscdi=true |